AMPH

Amphastar Pharmaceuticals, Inc.

54.78 USD
-0.66 (-1.19%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Amphastar Pharmaceuticals, Inc. stock is down -0.29% since 30 days ago. The next earnings date is May 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 February’s closed higher than January. In the last 8 Unusual Options Trades, there were 8 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 Jan 16:31 15 Mar, 2024 50.00 CALL 19 51
17 Jan 15:35 15 Mar, 2024 60.00 CALL 97 283
19 Jan 17:35 15 Mar, 2024 60.00 CALL 206 778
29 Jan 17:58 15 Mar, 2024 60.00 CALL 190 1199
16 Feb 18:19 15 Mar, 2024 65.00 CALL 300 55
23 Feb 16:28 19 Apr, 2024 30.00 CALL 10 0
27 Feb 15:46 19 Apr, 2024 30.00 CALL 10 10
28 Feb 20:17 15 Mar, 2024 50.00 CALL 50 87

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs.